Terms: = Kidney tumors AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Diagnosis
3 results:
1. The living donor evaluation as a life-saving event.
Park SC; Shapiro R; Good D; Lopez R; Shah N; Sood P; Sturdevant M; Tan H; Vekasy M; Wijkstrom M; Wu C; Humar A
Clin Transplant; 2023 Jan; 37(1):e14885. PubMed ID: 36562337
[TBL] [Abstract] [Full Text] [Related]
2. Targeting newly identified ERβ/TGF-β1/smad3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
Song W; He D; Chen Y; Yeh CR; Hsu I; Huang Q; Zhang X; Chang LS; Zuo L; Chen J; Doersch KM; Chang C; Li L; Yeh S
Mol Oncol; 2018 Dec; 12(12):2055-2071. PubMed ID: 30171816
[TBL] [Abstract] [Full Text] [Related]
3. Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein.
Bohr W; Kupper M; Hoffmann K; Weiskirchen R
PLoS One; 2010 Dec; 5(12):e16000. PubMed ID: 21209863
[TBL] [Abstract] [Full Text] [Related]
